Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAVOR: Iluvien in Macular Edema Secondary to Retinal Vein Occlusion
NCT00770770Phase 2Terminated
- Sponsor
- Alimera Sciences
- Start
- May 2009
- Primary completion
- Oct 2013
- Countries
- 1
01
Overview
A Phase 2 trial of fluocinolone acetonide intravitreal implant in retinal vein occlusion (RVO), sponsored by Alimera Sciences. Started May 2009; status: terminated.
02
Drugs
fluocinolone acetonide intravitreal implant
03
Conditions
retinal vein occlusion (RVO)
Beyond the preview
Go deeper on NCT00770770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770770.